The GBS Inc. Saliva Glucose Biosensor Analytics

The Saliva Glucose
Biosensor

The Saliva Glucose
Biosensor

Making Finger-pricking Obsolete

Our technology replaces the need for finger-prick blood glucose testing.

The Saliva Glucose Biosensor is the first non-invasive, saliva-based glucose test for diabetes management that measures glucose in saliva, not blood. Our innovative technology will free people living with diabetes from having to use painful and invasive blood monitoring devices to manage their condition, providing a better quality of life.

Through the regulatory process, we intend to demonstrate that the Saliva Glucose Biosensor can be used as a point of care self-test, indicated for the management of diabetes, non-adjunctive to blood glucose testing for diabetes treatment decisions.

* For illustrative purposes only and has yet to receive regulatory approval in any jurisdiction. * 

Place the Saliva Glucose Biosensor in contact with saliva.
The digital app displays the glucose measurement, flagging any data that needs attention.
The app provides real-time comparisons with historical data, and sends data to an electronic medical record or caregiver.

Predictive Analytics

The Saliva Glucose Biosensor System will allow the patient to achieve better glucose control through a practical understanding of lifestyle factors that affect glucose levels, helping prevent or delay diabetes complications and ultimately personalizing diabetes management.

At the patient’s or authorized carer’s requirement, data can be disseminated to a remote caregiver, a consultation service, or any other individual with whom the patient chooses to share their glucose level measurements.

Historic glucose
level comparison

Two-way
data flow

Improved Glucose
Management

Better Health
Outcomes

World-first Biosensor Platform​

A precise, accurate solution for measuring glucose in saliva.

The Saliva Glucose Biosensor is being developed from the Biosensor Platform, a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners. 

Because glucose concentrations are considerably lower in saliva than in capillary blood, detection sensitivity is of critical importance. 

The underlying Biosensor technology of the Saliva Glucose Biosensor shows a linear glucose response at concentrations 100 times more sensitive than commercial blood glucose sensors.

Future Outlook

THE PATIENT

  • Pain-free, non-invasive and easy-to-use
  • Receives alerts and reminders
  • Discrete and affordable

 

THE DOCTOR

  • Remote monitoring of patients and management of diabetes
  • Providing patient care beyond the clinic in real-time

 

HEALTHCARE SYSTEM

  • Reduces the cost of managing diabetes as it reduces hospitalization from comorbidities.
  • Greater collection of patient data opens significant opportunities to improve disease management

 

FAMILIES

  • Get updates in real-time, offering peace of mind
  • Parallel monitoring

THE PATIENT

  • Pain-free, non-invasive and easy-to-use
  • Receives alerts and reminders
  • Discrete and affordable


THE DOCTOR

  • Remote monitoring of patients and management of diabetes
  • Providing patient care beyond the clinic in real-time


HEALTHCARE SYSTEM

  • Reduces the cost of managing diabetes as it reduces hospitalization from comorbidities
  • Greater collection of patient data opens significant opportunities to improve disease management


FAMILIES

  • Get updates in real-time, offering peace of mind
  • Parallel monitoring

Future Outlook

Diabetes - A Global Epidemic

1
MILLION

people with diabetes worldwide by 2045

1 %
OF ADULTS

currently live with diabetes

1
million

adults are at increased risk of developing type 2 diabetes